XML 114 R88.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK-BASED INCENTIVE PLANS (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-Based Payment Award      
Aggregate number of shares authorized for issuance (in shares) 133,000,000    
Number of shares awarded to date (in shares) 16,000,000    
Number of shares counted for each share covered by an award in determining the number of shares that are available for future awards (in shares) 3    
Certain stock-based incentive amounts      
Compensation expense $ 287 $ 202 $ 208
Income tax benefit recognized in the income statement 60 $ 42 $ 43
Unrecognized compensation expense $ 225    
Weighted-average period over which unrecognized compensation expense is expected to be recognized 1 year 8 months 12 days    
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Issued (in shares) 2,522,000 36,130,000 3,188,000
Stock options, grant date fair value (in dollars per share) $ 12.72    
Options, weighted average strike price      
Options exercised (in shares) 0 0 0
Vested      
Outstanding stock options      
Stock options, number of shares outstanding, beginning balance (in shares) 1,326,000    
Granted (in shares) 0    
Vested (in shares) (910,000)    
Stock options, number of shares outstanding, ending balance (in shares) 2,236,000 1,326,000  
Options, weighted average strike price      
Stock options, weighted average strike price, beginning balance (in dollars per share) $ 55.38    
Stock options, granted, weighted average strike price (in dollars per share) 0    
Stock options, vested, weighted average strike price (in dollars per share) 40.03    
Stock options, weighted average strike price, ending balance (in dollars per share) $ 49.13 $ 55.38  
Unvested      
Outstanding stock options      
Stock options, number of shares outstanding, beginning balance (in shares) 1,900,000    
Granted (in shares) 440,000    
Vested (in shares) (910,000)    
Stock options, number of shares outstanding, ending balance (in shares) 1,430,000 1,900,000  
Options, weighted average strike price      
Stock options, weighted average strike price, beginning balance (in dollars per share) $ 40,030.00    
Stock options, granted, weighted average strike price (in dollars per share) 25.39    
Stock options, vested, weighted average strike price (in dollars per share) 40.03    
Stock options, weighted average strike price, ending balance (in dollars per share) $ 35.52 $ 40,030.00  
High end of range      
Share-based Compensation Arrangement by Share-Based Payment Award      
Maximum shares available for future issuance (in shares) 68,700,000    
Common Stock | Non-employee directors      
Share-based Compensation Arrangement by Share-Based Payment Award      
Restricted stock granted to non-employee directors (in shares) 88,802    
RSUs | Low end of range      
Certain stock-based incentive amounts      
Award vesting period 1 year    
RSUs | High end of range      
Certain stock-based incentive amounts      
Award vesting period 3 years    
Cash-Settled RSUs      
Certain stock-based incentive amounts      
Cash paid $ 4 $ 3 $ 4
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 5,457,000    
Granted (in shares) 190,000    
Vested (in shares) (166,000)    
Forfeitures (in shares) (106,000)    
Unvested, end of period (in shares) 5,375,000 5,457,000  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 42.41    
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) 25.83 $ 40.86 $ 42.62
Vested, Weighted-Average Grant-Date Fair Value (in dollars per share) 56.36    
Forfeitures, Weighted-Average Grant-Date Fair Value (in dollars per share) 40.08    
Unvested, end of period, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 41.44 $ 42.41  
Vested (in shares) 166,000    
Stock-Settled RSUs      
Certain stock-based incentive amounts      
Fair value of shares vested during the year $ 70 $ 62 $ 148
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 5,856,000    
Granted (in shares) 5,773,000    
Vested (in shares) (2,750,000)    
Forfeitures (in shares) (290,000)    
Unvested, end of period (in shares) 8,589,000 5,856,000  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 50.21    
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) 25.45 $ 41.60 $ 58.73
Vested, Weighted-Average Grant-Date Fair Value (in dollars per share) 53.27    
Forfeitures, Weighted-Average Grant-Date Fair Value (in dollars per share) 35.07    
Unvested, end of period, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 33.10 $ 50.21  
Payouts for share-based awards granted as a percentage of target 95.00%    
Issued (in shares) 2,605,000    
Vested (in shares) 2,750,000    
TSRIs      
Certain stock-based incentive amounts      
Award vesting period 3 years    
Fair value of shares vested during the year $ 4 $ 9 $ 4
Grant-date assumptions used in the Monte Carlo simulation models      
Risk-free interest rate (as a percent) 0.20% 1.40% 2.50%
Volatility factor (as a percent) 75.00% 26.00% 22.00%
Expected life (years) 2 years 10 months 17 days 3 years 3 years
Grant-date fair value of underlying Occidental common stock (in dollars per share) $ 25.39 $ 41.60 $ 67.19
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 1,534,000    
Granted (in shares) 665,000    
Vested (in shares) (420,000)    
Forfeitures (in shares) (10,000)    
Unvested, end of period (in shares) 1,769,000 1,534,000  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 58.02    
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) 25.39    
Vested, Weighted-Average Grant-Date Fair Value (in dollars per share) 69.87    
Forfeitures, Weighted-Average Grant-Date Fair Value (in dollars per share) 25.39    
Unvested, end of period, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 43.12 $ 58.02  
Payouts for share-based awards granted as a percentage of target 34.00%    
Issued (in shares) 145,000    
Vested (in shares) 420,000    
TSRIs | Low end of range      
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Payouts for share-based awards granted as a percentage of target 0.00%    
TSRIs | High end of range      
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Payouts for share-based awards granted as a percentage of target 200.00%    
Options      
Certain stock-based incentive amounts      
Award vesting period 3 years    
Grant-date assumptions used in the Monte Carlo simulation models      
Risk-free interest rate (as a percent) 0.70%    
Volatility factor (as a percent) 55.00%    
Expected life (years) 6 years    
Dividend yield 0.16%    
Grant-date fair value of underlying Occidental common stock (in dollars per share) $ 25.39    
Option and SAR transactions      
Options, weighted average strike price      
Remaining life of options 6 years 10 months 24 days    
CROCEI awards      
Certain stock-based incentive amounts      
Award vesting period 3 years    
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 197,000    
Granted (in shares) 221,000    
Unvested, end of period (in shares) 418,000 197,000  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 41.60    
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) 25.39    
Unvested, end of period, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 33.03 $ 41.60  
CROCEI awards | Low end of range      
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Payouts for share-based awards granted as a percentage of target 0.00%    
CROCEI awards | High end of range      
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Payouts for share-based awards granted as a percentage of target 200.00%